메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
이영훈 (영남대학교 약학대학) 박정규 (영남대학교병원 약제부) 최혜덕 (영남대학교)
저널정보
한국병원약사회 병원약사회지 병원약사회지 제37권 제4호
발행연도
2020.1
수록면
471 - 484 (14page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background : Acute pancreatitis is an important and serious disease even with a relatively low incidence. Also, previous studies suggest that the coexistence of Type 2 diabetes and acute pancreatitis is closely related to an increased risk of death. However, the risk of acute pancreatitis in patients treated with liraglutide, a GLP-1 receptor agonist, has not been adequately evaluated. Objective : This meta-analysis was conducted to investigate the association between the liraglutide and acute pancreatitis in patients with Type 2 diabetes. Methods : Forty-one studies were assessed, and the results of the included studies were quantitatively integrated using the meta-analysis. The incidence of the liraglutide-related acute pancreatitis was estimated. As a sub-group analysis, four studies were assessed for comparing the liraglutide-treated groups and the control groups (placebo or other antidiabetic drugs except GLP-1 receptor agonists). Results : The incidence of acute pancreatitis was 0.4% (95% confidence interval (CI) 0.3%-0.5%). The risk of acute pancreatitis was not significantly different between the liraglutide-treated groups and the control groups (odds ratio=1.412; 95% CI 0.290-6.866). Conclusion : The incidence of liraglutide-related acute pancreatitis was relatively low and not additionally increased compared to the other antidiabetic drugs. We suggest that this meta-analysis is meaningful as evidence for the clinical use of liraglutide.

목차

등록된 정보가 없습니다.

참고문헌 (60)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0